NewGenIvf Group (NIVF) Stock Price, News & Analysis

NewGenIvf Group Limited (NASDAQ: NIVF) is described in its public disclosures as a tech-forward, diversified, multi-jurisdictional company with roots in fertility services and an expanding focus on technology, digital assets, and real estate development. The company is associated with the healthcare sector through its fertility operations and is also active in areas such as blockchain-enabled tokenization and property development.

According to multiple company press releases, NewGenIvf began as a comprehensive fertility services provider in Asia, helping couples and individuals obtain access to fertility treatments. Its legacy business involves operating fertility centers that offer in-vitro fertilization (IVF), assisted reproductive technology, gamete (egg and sperm) donation, and surrogacy services in appropriate jurisdictions. These clinics are located in Thailand, Cambodia, and Kyrgyzstan, and are focused on supporting patients facing infertility challenges.

Recent company communications describe a strategic pivot toward a technology-driven model centered on proprietary reproductive technologies. NewGenIvf has acquired advanced cytometry intellectual property and equipment and has also acquired MicroSort sperm-sorting technology. The company states that these assets support a transition from traditional IVF services to a technology licensing and fertility technology platform, with an emphasis on high-margin, capital-light revenue streams such as licensing, royalties, and the supply of proprietary consumables to fertility service providers.

Business Divisions and Diversified Ecosystem

NewGenIvf’s disclosures describe a diversified structure built around three primary business divisions:

• NewGenProperty – the group’s real estate development arm, focused on projects in the United Arab Emirates.
• NewGenDigital – the digital asset and decentralized finance (DeFi) division, responsible for tokenization and digital asset strategies.
• NewGenSup – a division focused on health and longevity products and solutions.

In addition to these divisions, the company continues to refer to its legacy IVF and assisted reproductive treatment services across Asia as an important part of its overall profile, even as it emphasizes a pivot to technology-driven offerings.

Fertility Technology and Licensing Focus

In an October 2025 press release, NewGenIvf highlighted the acquisition of advanced cytometry intellectual property and related equipment. The company characterizes this transaction as a transformative step that supports its transition from operating IVF clinics to becoming a technology-driven service provider in the fertility sector. The acquired intellectual property is associated with advanced cytometry technology, and NewGenIvf states that it intends to generate recurring revenue by licensing this technology, collecting royalty fees, and supplying proprietary consumables to fertility service clinics.

The company has also reported the acquisition of the MicroSort sperm-sorting technology, which it describes as enhancing its capabilities in the fertility services market. Together, these assets are presented as forming the core of a fertility technology platform that NewGenIvf aims to commercialize through a licensing model.

Digital Asset and Tokenization Activities

NewGenIvf’s public statements describe an active strategy in digital asset management and tokenization, conducted primarily through its NewGenDigital division. The company has announced a Solana (SOL) treasury strategy, including plans to invest up to a specified amount in Solana and the accumulation of Solana tokens as part of its digital asset portfolio.

NewGenIvf has also entered into agreements to act as a tokenization agent for real-world assets. One engagement involves tokenizing a private art collection owned by World Chinese Museum Co., Ltd., with an initial tranche valued at a stated amount and the possibility of expansion to a larger notional value. Under that agreement, NewGenIvf reports that it will earn a fee calculated as a percentage of the total value of tokenized assets.

In another disclosed arrangement, NewGenDigital has been appointed as the worldwide agent for the tokenization of gold-backed assets associated with SAXA, Inc. The engagement letter provides for an initial tranche of gold-backed assets to be tokenized and includes provisions to expand the tokenization value, with NewGenDigital earning a commission on tokenized assets sold. These activities are presented by the company as part of a broader digital asset and DeFi strategy that includes real-world asset tokenization.

Real Estate Development in the UAE

Through NewGenProperty, NewGenIvf has disclosed a joint venture and subsequent joint development structure related to a plot of land in the Beach District of Ras Al Khaimah in the United Arab Emirates. The company initially entered into a joint venture agreement with BNW Real Estate Development LLC to develop this plot, with NewGenProperty holding a majority interest in the joint venture.

Later, NewGenIvf announced its intention to exercise an option under the joint venture agreement to convert the arrangement into a joint development structure. Under this structure, NewGenProperty, as the landowner, is responsible for funding the project’s finances, including the plot purchase price, development costs, pre-sales expenses, and financial escrow requirements. BNW continues as the developer, providing development management services. The company states that, following the conversion, NewGenProperty will be entitled to a specified percentage of net profits from the project, with the remainder allocated to BNW after deducting SPV-related expenses, taxes, and costs.

NewGenIvf’s disclosures characterize this Ras Al Khaimah project as a flagship luxury real estate development and a key component of its diversification strategy, with feasibility analyses prepared by BNW indicating potential net returns and projected pre-tax profit increases under the revised structure.

Digital Asset Treasury and Financing Arrangements

The company has reported several financing and capital structure initiatives. These include a Securities Purchase Agreement for the issuance of senior convertible notes with an aggregate principal amount up to a specified level, intended to fund strategic initiatives. NewGenIvf has also entered into a Digital Assets Purchase Agreement term sheet with White Lion Capital LLC, under which the company has the option to sell shares over a defined period in exchange for Solana tokens rather than cash. This structure is described as supporting the company’s Solana treasury strategy.

In addition, NewGenIvf has disclosed multiple reverse stock splits approved by its board of directors and implemented over time, with explanatory 6-K filings describing the exchange ratios, effective dates, and resulting adjustments to outstanding Class A ordinary shares and related securities. The company has also announced a share repurchase program authorizing the repurchase of up to a specified dollar amount of its Class A ordinary shares over a defined period, subject to market conditions and applicable regulations.

Proposed Reverse Merger and Mining Asset Exposure

NewGenIvf has announced the execution of a non-binding term sheet for a proposed reverse merger with SAXA, Inc., an international holdings company focused on mining and processing operations. Under the proposed transaction, NewGenIvf would issue new Class A ordinary shares to SAXA shareholders in exchange for specific mining assets, including an Arizona mine and a California mine, with associated mineral resource and revenue estimates described in the company’s press release.

The company states that, if completed, this proposed transaction would provide access to a portfolio of mining assets and would significantly affect the ownership structure of NewGenIvf. However, the company also notes that the completion of the proposed transaction is subject to due diligence, negotiation of definitive agreements, financing, regulatory and corporate approvals, and other conditions, and that there can be no assurance that the transaction will be consummated.

Regulatory Filings and Listing

NewGenIvf files reports with the U.S. Securities and Exchange Commission as a foreign private issuer on Form 20-F and Form 6-K. The company’s Class A ordinary shares trade on the Nasdaq Capital Market under the symbol NIVF, as confirmed in multiple press releases and 6-K filings. Several 6-K filings detail reverse stock splits and related adjustments to the company’s capital structure, as well as interim and unaudited financial information furnished as exhibits.